In Boca Raton, like many other areas, obesity is a growing concern, impacting overall health and well-being
Space and Health: A long Success Story of Synergies , Johnson, I
However, it is the leading cause of morbidity resulting in about 4 million stroke survivors each year [1]
As of July 2025, the FDA got 605 adverse event reports tied to compounded semaglutide, but the real numbers probably higher
BALANCE is the longer-term program that will allow Part D plans to cover GLP-1 medications for weight management beyond the Bridge
Skip to Content About Us Toggle About Us Menu Mission People News Our Work Contact Fair Allocation of GLP-1 and Dual GLP-1GIP Receptor Agonists Emanuel EJ, Dellgren JL, McCoy MS, Persad G LINK TO MANUSCRIPT Fair-Allocation Framework for GLP-1 and Dual GLP-1GIP Receptor Agonists (NEJM, 2024) Menu About Us About Us Mission People News Our Work Contact twitter youtube Search Search